ZYBERNO
Stock Report
Updated Aug 22, 2026

BON NATURAL LIFE LIMITED (BON)

Healthcare • NASDAQ

$1.14

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
BON NATURAL LIFE LIMITED (BON) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.04x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-1.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

BON NATURAL LIFE LIMITED (BON) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.14
Market Cap:$9.68M

Valuation Multiples (3)

P/B Ratio:0.17x
P/S Ratio:0.52x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$17.00M
Pfcf Ratio:69.55x

Price Action & Momentum (3)

Momentum Percentile:33 / 100
% of 52-Week High:33.5%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:88.8%
Fundamental Growth Rate (g):-1.7%

Margin Analysis (1)

Ebitda Margin:-3.1%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.74x
Quick Ratio:1.61x
Cash Ratio:0.14x

Leverage Analysis (3)

Debt To Equity Ttm:0.04x
Debt-to-Equity Ratio:0.04x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-4.43x
Times Interest Earned:-4.43

Capital Structure (4)

Working Capital:19,451,991.00
Cash And Cash Equivalents:3,765,978.00
Long Term Debt:$842.82K
Net Debt:$7.33M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$18.67M
Cost Of Revenue Ttm:$14.79M

Profitability Breakdown (2)

$3.88M-$1.62M

Bottom Line Performance (3)

-$1.99M
Income Before Tax:-$1.71M
Ebitda Ttm:-574,329.00

Operating Expenses (5)

Operating Expenses:5,502,036.00
R And D Expense:754,193.00
Sga Expense:4,310,910.00
Income Tax Expense:$339.41K
Interest Expense:366,180.00

Expense Ratios (3)

R And D To Revenue Percentage:4.0%
Sga To Revenue Percentage:23.1%
Ebitda Margin:-3.1%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$85.19M
Current Assets:$45.76M
Ppe Net:18,158,289.00
Goodwill:0.00
Intangible Assets:$6.42M

Liability Structure (4)

Total Liabilities:27,187,876.00
Current Liabilities:26,308,460.00
Long Term Debt:$842.82K
Short Term Debt:$10.25M

Equity & Capital (3)

Equity:$58.00M
Retained Earnings:$16.63M
Common Stock:270,000,000.00

Working Capital Items (3)

Accounts Receivable:11,012,741.00
Inventory:3,305,438.00
Accounts Payable:7,641,274.00

Special Items (2)

Contract Liabilities:9,800,000.00
Stock Based Compensation:1,393,573.00
C. Cash Flow Analysis

Operating Activities (2)

$141.12K$134.29K

Investment Activities (1)

Investing Cash Flow:-$10.00M

Financing Activities (3)

Financing Cash Flow:$15.45M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$340.10K

Non-Cash Items (1)

Depreciation Amortization Ttm:1,048,886.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$0.23

Revenue & Cash Per Share (2)

Sales Per Share Ttm:2.20
Operating Cash Flow Per Share:$0.02

Book Value & Capital (2)

Book Value Per Share:$6.83
Cash Per Share:0.44

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.22x
Working Capital Turnover Ttm:0.96x

Receivables Management (2)

Receivables Turnover Ttm:1.70x
Days Sales Outstanding Ttm:215.29

Inventory Management (2)

Inventory Turnover Ttm:4.48x
Days Inventory Outstanding Ttm:81.56

Payables & Cash Cycle (2)

Days Payable Outstanding:188.55
Cash Conversion Cycle:108.30
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:50.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:88.8%
Fundamental Growth Rate (g):-1.7%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:BON
Company Name:BON NATURAL LIFE LIMITED
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:NASDAQ
Country:China

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.49M
Shares Outstanding Basic:2.76M
Shares Outstanding Diluted:2.76M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-22 23:53:52 UTC
Data Timestamp:2026-08-21T12:13:38.905358
Scroll to Top